by Carl Kukkonen | Dec 14, 2023 | PTAB News, PTAB Trial Basics, Request for Reconsideration, Trial Institution
By Ben Baek* and Carl Kukkonen – On November 16, 2023, USPTO Director Kathi Vidal ordered a Delegated Rehearing Panel (“DRP”) to review whether the PTAB misapprehended or overlooked certain issues when denying challenger SynAffix B.V.’s petition for inter partes...
by Matthew Johnson | Dec 12, 2023 | Prior Art Issues, PTAB News, PTAB Trial Basics
By Pranita Dhungana and Matt Johnson – The PTAB recently denied IPR institution in Sophos v. Open Text because the petitioner failed to show a reasonable likelihood that the asserted reference was, in fact, prior art. IPR2023-00732, Paper 23 (November 2, 2023)....
by Emily Tait | Dec 8, 2023 | Federal Circuit Appeal, PTAB News, PTAB Trial Basics
By Evan Jones and Emily Tait – In a recent decision, the Federal Circuit found no abuse of discretion by the Board when it allowed Apple to expand its analogous art contention in its IPR reply, finding that the Board’s decision did not run afoul of the “newness”...
by Albert Liou | Dec 5, 2023 | Motions Practice, PTAB News, PTAB Trial Basics
By Albert Liou and Daniella Paredes – In Nanobebe US Inc. v. Mayborn (UK) Limited et al., the PTAB denied a Petitioner’s Motion to submit supplemental information, even though Petitioner argued the information had been inadvertently omitted in the original...
by David Maiorana | Nov 21, 2023 | PTAB News, PTAB Trial Basics, Trial Institution
By David Linden and Dave Maiorana – On March 31, 2023, Zhuhai CosMX Battery Co., Ltd. (“Zhuhai”) filed a petition for inter partes review (“IPR”) of claims of U.S. Patent No. 11,329,352 (“the ’352 Patent”), assigned to Ningde Amperex Technology Ltd....
by Matthew Johnson | Nov 17, 2023 | Final Written Decisions, PTAB News, PTAB Trial Basics, Trial Institution
By Christian Roberts and Matthew Johnson – On October 6, 2023, the United States Patent and Trademark Office (“USPTO”) issued a Notice of Proposed Rulemaking (“NPR”) making changes to the Patent Trial and Appeal Board’s (“PTAB”) internal circulation and review...